Investors Rediscover High Tech

WASHINGTON—The bull market that helped boost the Dow Jones Industrial Average to its record highs last month has been fueled in part by technology stocks, and some analysts are predicting steady—if spotty—growth for that sector for the rest of the year. "From an economic standpoint, the second quarter [of 1986] was the bottom in terms of GNP, interest rates, computer manufacturing orders and shipments," said John C. Maxwell, senior analyst at Dillon Read & Co. Inc. in New York.

Written byStephen Greene
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"From an economic standpoint, the second quarter [of 1986] was the bottom in terms of GNP, interest rates, computer manufacturing orders and shipments," said John C. Maxwell, senior analyst at Dillon Read & Co. Inc. in New York. "The slope of growth from that point is positive but very slow, with few exceptions," he said. "The ones doing well are those in applications technology, rather than enabling technology."

Digital Equipment Corporation, Cray Research, Microsoft, Seagate Technology, Hewlett Packard and other computer-related companies saw their stock prices shoot up 30 percent or more in the first few weeks of the year, before profit taking checked their rise.

"Technology stocks have been undervalued relative to the rest of the market for a long time," noted Derek Penn, senior equity trader at Morgan Stanley Co. in New York. "High tech has been out of favor for the last six months at least," thanks ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies